Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
28.24
-1.75 (-5.84%)
At close: Oct 30, 2026, 4:00 PM EDT
28.43
+0.19 (0.67%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Harrow Market Cap
Harrow has a market cap or net worth of $1.06 billion as of October 30, 2026. It is the 9,574th most valuable company in the world and the 2,193rd biggest in the United States. Its market cap has decreased by 22.21% in one year.
Market Cap
1.06B
Enterprise Value
1.27B
1-Year Change
-22.21%
Global Rank
Country Rank
#2,193 United States
Category
ChartMarket Cap Chart
Since September 28, 2007, Harrow's market cap has increased from $22.20M to $1.06B, an increase of 4,668.72%. That is a compound annual growth rate of 22.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.06B | -41.66% |
| Dec 31, 2025 | 1.81B | 51.88% |
| Dec 31, 2024 | 1.19B | 203.81% |
| Dec 29, 2023 | 393.30M | -2.79% |
| Dec 30, 2022 | 404.60M | 74.10% |
| Dec 31, 2021 | 232.40M | 31.60% |
| Dec 31, 2020 | 176.60M | -9.81% |
| Dec 31, 2019 | 195.80M | 47.77% |
| Dec 31, 2018 | 132.50M | 279.66% |
| Dec 29, 2017 | 34.90M | 5.44% |
| Dec 30, 2016 | 33.10M | -50.67% |
| Dec 31, 2015 | 67.10M | -3.31% |
| Dec 31, 2014 | 69.40M | 130.56% |
| Dec 31, 2013 | 30.10M | -53.19% |
| Dec 31, 2012 | 64.30M | 3,284.21% |
| Dec 30, 2011 | 1.90M | -85.04% |
| Dec 31, 2010 | 12.70M | -45.96% |
| Dec 31, 2009 | 23.50M | 51.61% |
| Dec 31, 2008 | 15.50M | -58.89% |
| Dec 31, 2007 | 37.70M | 69.82% |
| Sep 28, 2007 | 22.20M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Trulieve Cannabis | 1.98B |
| Xeris Biopharma Holdings | 1.95B |
| Alvotech | 1.66B |
| Phibro Animal Health | 1.58B |
| ANI Pharmaceuticals | 1.54B |
| Eton Pharmaceuticals | 1.49B |
| Pacira BioSciences | 1.45B |
| Cronos Group | 1.22B |